Gravatom has experienced a surge in interest in its PET (Positron Emission Tomography) engineering solutions developed for the nuclear
medicine industry. PET is a vital nuclear imaging technique for the earlier detection of cancers, brain and cardiovascular disorders. Over the past
four years, Gravatom has been applying its extensive knowledge of engineering for GMP production of radiopharmaceuticals towards the
development of systems for the production of PET tracer. For more information please contact Gravatom on 01489 897300, email sales@gravatom.com or visit www.gravatom.com
For more information on this company click here
To add your company click here
Virgin Atlantic’s Flight100 saved 95 tonnes of CO2 in first SAF flight
Good comment. I think these reports are different from many others , in that they were prepared outside the government and the issues, they raised, of...